Table 3.

Independent risk factors associated with CMS-induced AKI among adult inpatients who received colistimethate sodium for ≥48 h as determined by multivariate logistic regression analysis.

Independent Risk Factor	CMS-Induced AKI
	aOR (95% CI)	p-Value
Age ≥ 75 years	1.854 (1.060–3.241)	0.030
Baseline chronic kidney disease	4.849 (2.618–9.264)	<0.0001
Concomitant use of vasopressors during CMS therapy	4.305 (2.517–7.456)	<0.0001

Abbreviations: AKI = acute kidney injury, CMS = colistimethate sodium, aOR = adjusted odds ratio, CI = confidence interval.